CNP and cardiac hypertrophy: Together, NO and C-type natriuretic peptide (CNP) contribute to the suppression of cardiac hypertrophy by up-regulating cyclic GMP (cGMP)-dependent protein kinase 1 (PKGI) signaling [43] by inhibiting calcineurin (Figure 2).